IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Supernus Pharmaceuticals 144A

CUSIP: 868459AC2 | 2 institutional holders

Quarters

Q1 2019Q1 2018
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2019

Wellesley Asset Management37,527
2.6% of portfolio›$36.5K
StyleTurnoverLocationFiled
Wellesley Asset Management
37,527$36.5K2.6%N/AN/APortsmouth, NH2019-05-07